The present invention relates to a method for producing telomerase activators which provide to obtain new / novel molecules (metabolites) from saponin group compounds by using biotransformation with endophytic fungi and telomerase activators obtained by this method. The scope of the invention is the elucidation of chemical structures and investigation of the effects of telomerase enzyme activation in cells. These molecules have the potential to be used in diseases and / or conditions that can be treated / ameliorated by telomerase activation and associated with telomere shortening (For example； HIV, degenerative diseases, acute and chronic wound healing, ex vivo cell therapies and stem cell proliferation due to increment in vitro and ex-vivo replicative capacity of cells).
